What Can I Give My Dog For Pain? — Safe Medications, Natural Remedies & What to Avoid

Carprofen is among the longest-established FDA-approved NSAIDs for dogs, with decades of use and a well-characterized safety profile. It reduces inflammation and pain in dogs with osteoarthritis, hip dysplasia, and post-operative discomfort after soft tissue or orthopedic surgery. Available as chewable tablets (making daily dosing easier for dogs that resist pills), film-coated tablets, and caplets. Baseline bloodwork is required before starting — carprofen affects kidney and liver function in some dogs, and pre-existing disease can increase risk. Dogs on long-term carprofen should have follow-up blood panels every six months. Signs to watch for: changes in appetite, increased thirst, vomiting, dark or tarry stools. Stop and call your vet immediately if any of these appear.

Meloxicam is a COX-2 selective NSAID that controls pain and inflammation associated with osteoarthritis and post-operative pain. It is available as an oral liquid with a dosing syringe, which makes precise weight-based dosing straightforward, and as tablets. Meloxicam is commonly used in older dogs because the oral liquid formulation allows very small dose adjustments. Kidney function monitoring is particularly important with long-term meloxicam use — dogs with pre-existing kidney disease require reduced dosing or may not be candidates at all. As with all prescription NSAIDs, it should never be combined with corticosteroids (prednisone, dexamethasone) or with another NSAID. A washout period of several days is required before switching from any NSAID to another.

Grapiprant operates through a more targeted mechanism than older NSAIDs — instead of broadly suppressing the entire prostaglandin pathway (which has GI and kidney protective functions), it specifically blocks the EP4 receptor that is most responsible for pain and inflammation in arthritic joints. This precision is why many veterinarians now reach for it first, particularly for dogs where GI sensitivity or early kidney concerns make broader COX-inhibiting NSAIDs less desirable. Galliprant is a chewable flavored tablet given once daily. It is approved specifically for controlling pain and inflammation of osteoarthritis in dogs — not for post-surgical pain or other conditions. While it has a favorable safety profile, it still requires veterinary prescription and should not be given to dogs with severe liver or kidney impairment.

Gabapentin is not FDA-approved for dogs but is legally and commonly prescribed off-label for chronic pain, nerve pain, spinal conditions, and intervertebral disc disease. Research from the University of Milan (Animals, 2023) and the Merck Veterinary Manual both document its benefit for neuropathic and chronic musculoskeletal pain in dogs. It works through a different mechanism than NSAIDs, which means the two classes can be combined for better overall pain control — a strategy veterinary pain specialists refer to as multimodal analgesia. Standard dosing ranges from 5–30 mg/kg given two to three times daily, though veterinarians adjust this significantly based on the individual dog. Sedation is the most common side effect and often resolves within a few days or with dose adjustment. Important: gabapentin liquid formulations made for humans often contain xylitol, which is highly toxic to dogs — only use a formulation your vet has specifically prescribed or approved.

Librela was approved in May 2023 as the first monoclonal antibody for osteoarthritis pain in dogs, offered as a monthly subcutaneous injection. For many dogs, it has provided meaningful arthritis pain relief. However, the FDA’s post-marketing surveillance identified 18 distinct safety signals, including neurological events (ataxia, seizures, partial paralysis), urinary incontinence, and deaths. In 3,674 adverse event reports reviewed by the FDA, 70% of cases showed signs after the very first dose, and 30% showed signs within the first day. A 2025 peer-reviewed study found musculoskeletal events approximately nine times more frequent in Librela-treated dogs than in dogs on other arthritis medications. The FDA added joint swelling and bone and joint disorder to the label as rare adverse events in May 2026. Librela may still be appropriate for specific dogs — this requires an informed, documented conversation with your veterinarian about the benefit-risk profile for your individual pet.

Fish oil containing EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) has among the strongest evidence of any supplement for canine arthritis. Multiple studies published in JAVMA (Journal of the American Veterinary Medical Association) confirm that omega-3 supplementation improves mobility and reduces inflammatory markers in arthritic dogs. The mechanism is direct: EPA and DHA are incorporated into joint cell membranes and reduce the production of pro-inflammatory eicosanoids. PetMD (December 2024 update) notes particular benefit for senior dogs and those with osteoarthritis or itchy, inflamed skin. Use a veterinary-grade product formulated for dogs — some fish species used in human fish oil contain elevated levels of toxic metals. Also check for xylitol in any flavored formulation. The dose is body-weight dependent; your vet can provide a specific recommendation.

Glucosamine and chondroitin are naturally occurring compounds found in cartilage tissue. Glucosamine supports the growth of cartilage cells; chondroitin works by inhibiting enzymes that break cartilage down. Studies reviewed by PetMD (December 2024) indicate that dogs with joint conditions benefit from both, with the combination outperforming either alone. These supplements do not provide immediate pain relief — they work over weeks by supporting the underlying joint structure rather than masking symptoms. Give them consistently for at least 6–12 weeks before assessing effectiveness. Multiple formulations of glucosamine exist (glucosamine HCl vs. glucosamine sulfate) — ask your vet which form and dose is appropriate for your dog’s weight and condition. Human glucosamine products are generally safe for dogs in appropriate doses, but dog-specific formulations without unnecessary additives are preferable.

Green-lipped mussel (Perna canaliculus), harvested from New Zealand, contains an unusual combination of glucosamine, chondroitin, and omega-3 fatty acids that includes unique compounds called ETA (eicosatetraenoic acid) not found in standard fish oil. Many veterinary practitioners consider it among the most effective natural joint supplements for dogs because the synergy between its components appears to produce better results than any single ingredient alone. Multiple vet-reviewed sources including The Pet Vet (January 2026) cite it as a first-choice natural recommendation for arthritic dogs. Because it is a shellfish product, check for shellfish allergies before starting, particularly in dogs that have shown food sensitivities. Use a concentrated, standardized extract rather than a raw powder to ensure consistent dosing.

Curcumin, the active anti-inflammatory compound in turmeric, inhibits inflammatory pathways at the cellular level. A 2024 study published in Frontiers in Veterinary Science found that curcumin may help reduce discomfort in dogs with arthritis. The critical practical point: curcumin absorption is very poor without a bioavailability enhancer. Only use formulations that explicitly include black pepper extract (piperine) or a specialized delivery system — plain turmeric powder has negligible absorption and will accomplish little. Plain turmeric in large amounts can also cause GI upset. Start at a low dose and increase gradually. Tell your vet if your dog is on any blood-thinning medications — curcumin has mild anticoagulant properties.

For arthritic and aging dogs, non-pharmaceutical measures often produce relief equivalent to a low-dose NSAID. Every extra pound your dog carries puts disproportionate stress on already-compromised joints — even modest weight loss in overweight arthritic dogs produces measurable improvements in pain scores in multiple veterinary studies. Environmental modifications: orthopedic foam beds (4+ inches thick) reduce joint pressure during the 12–16 hours a day most dogs spend resting; ramps instead of stairs eliminate the repetitive joint impact that makes morning stiffness worse; non-slip mats on hard floors prevent the muscle tension dogs develop compensating for slippery surfaces. Gentle, low-impact exercise — short leash walks on flat ground, swimming if available — maintains muscle mass that supports arthritic joints without overloading them. Avoiding long rest followed by sudden exertion (the classic “stiff after sleeping” pattern) is more manageable with two to three short walks per day rather than one long one.

Veterinary acupuncture, cited in a 2018 World Small Animal Veterinary Association Congress review, has documented evidence for managing chronic musculoskeletal pain in dogs. Multiple peer-reviewed studies support its use as an adjunct (alongside medications) rather than a sole treatment for significant pain. Therapeutic laser (Class IV cold laser) delivers targeted light energy to inflamed tissue, reducing cytokine activity and improving circulation in painful joints — commonly used post-surgically and for arthritis. Both are administered by trained veterinary practitioners. They do not replace NSAIDs in cases of moderate-to-severe pain but can meaningfully reduce the dose of pharmaceutical pain medication needed, which matters for dogs whose kidneys or stomach make high-dose NSAIDs risky. Look for a veterinarian certified in veterinary acupuncture through the Chi Institute or IVAS (International Veterinary Acupuncture Society).